How many insider trades does FilingIQ track for PVLA?

FilingIQ tracks 54 Form 4 insider transactions for PVLA (PALVELLA THERAPEUTICS, INC.), covering filings from Dec 13, 2024 onwards. 26 of those were filed in the last 90 days.

Are PVLA insiders net buyers or net sellers?

Across the full Form 4 history for PVLA, 6 transactions (11%) were open-market purchases and 15 (28%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does PVLA insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is PVLA in?

PALVELLA THERAPEUTICS, INC. (PVLA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $929.58M.

PVLA insider trading

Healthcare

PALVELLA THERAPEUTICS, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

11% / 28%

Market cap

$929.58M

About PALVELLA THERAPEUTICS, INC.

Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases. The company's lead product candidate is QTORIN 3.9% rapamycin anhydrous gel that is in Phase 3 clinical trial for the treatment of microcystic lymphatic malformations, as well as in Phase 2 clinical trial to treat cutaneous venous malformations. It also develops QTORIN rapamycin for the treatment of other mTOR-driven skin diseases. The company is based in Wayne, Pennsylvania

Company website: palvellatx.com

PVLA insider activity at a glance

FilingIQ has scored 54 insider transactions for PVLA since Dec 13, 2024. The most recent filing in our index is dated Apr 15, 2026.

Across the full history, 6 open-market purchases and 15 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on PVLA insider trades is 52.8/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live PVLA trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for PVLA?: FilingIQ tracks 54 Form 4 insider transactions for PVLA (PALVELLA THERAPEUTICS, INC.), covering filings from Dec 13, 2024 onwards. 26 of those were filed in the last 90 days.
Are PVLA insiders net buyers or net sellers?: Across the full Form 4 history for PVLA, 6 transactions (11%) were open-market purchases and 15 (28%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does PVLA insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is PVLA in?: PALVELLA THERAPEUTICS, INC. (PVLA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $929.58M.

Methodology & sources

Every PVLA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.